BICO's Board of Directors has appointed Erik Gatenholm as Board Chair
The Board of Directors has with immediate effect among its members elected Erik Gatenholm to serve as Board Chair of BICO Group AB, until a new Board Chair has been elected by the extraordinary shareholders’ meeting.
Erik Gatenholm succeeds Maria Rankka who announced in a press release, from the company on July 6, 2026, that she will be stepping down from her board position and her role as Board Chair effective July 31, 2026.
The Board of Directors intends to resolve to convene an Extraordinary General Meeting to elect new Board members. Notice to the Extraordinary General Meeting will be published separately in accordance with applicable regulations.
For further information, please contact:
Maria Forss, President & CEO, BICO Group AB
Phone: EA Elisabeth Lindell +46 761 73 40 59
E-mail: mf@bico.com
Ewa Linsäter, Chief Financial Officer, BICO Group AB
Phone: +46 766 33 32 33
E-mail: ewa.linsater@bico.com
About BICO
BICO leverages a global portfolio of pioneering brands fusing automation, intelligence, and data to unlock scientific discovery at scale in pharma and biotech. With 53,600+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 13,000 publications. BICO strives towards the vision to enable life-science labs to accelerate the discoveries that change lives. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com